top of page
About us
Our
Story
We are a Finnish biotechnology spin-off company from University of Helsinki, focused on developing innovative medical therapeutics for neurodegenerative diseases. Our company was founded in 2024, and our premises are located in Helsinki.
Team
Curiosity. Expertise. Determination.
Our roots are deep in science, and we have decades worth of experience in the research fields of regenerative- and neuropharmacology, as well as neuroinflammation. Our mission is to address the unique needs of the patients of neurological diseases through cutting-edge therapeutical inventions.
CEO, Co-founder
Merja Voutilainen
Associate professor in regenerative pharmacology at University of Helsinki
Chairman, Co-founder
Mikko Airavaara
Professor in pharmacology and drug development at University of Helsinki
bottom of page